We next performed an in silico analysis of mRNA expression levels in patient-derived samples and observed that in prostate carcinomas and certain breast carcinomas, PIM expression was elevated and LKB1/STK11 expression was reduced (Additional file 2: Figure S7). This evidence concerns the gene PIM1 and breast carcinoma.